Iridex (IRIX) EBT Growth (5y) (2015 - 2026)
Iridex (IRIX) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn |
| 10 | Iridex | 13.03 Mn | 8.35 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 25.29% |
| Sep 27, 2025 | 1.72% |
| Jun 28, 2025 | 18.91% |
| Mar 29, 2025 | -0.36% |
| Dec 28, 2024 | 11.36% |
| Sep 28, 2024 | -1.51% |
| Jun 29, 2024 | -1.99% |
| Mar 30, 2024 | -2.41% |
| Dec 30, 2023 | -7.19% |
| Sep 30, 2023 | 10.66% |
| Jul 1, 2023 | 3.40% |
| Apr 1, 2023 | 10.40% |
| Dec 31, 2022 | 26.26% |
| Oct 1, 2022 | 10.70% |
| Jul 2, 2022 | 4.10% |
| Apr 2, 2022 | -4.97% |
| Jan 1, 2022 | 23.49% |
| Oct 2, 2021 | -10.69% |
| Jul 3, 2021 | 39.99% |
| Apr 3, 2021 | -74.54% |